Deferred Tax Assets, Net of Valuation Allowance of CANNAPHARMARX, INC. from 31 Dec 2013 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary: CANNAPHARMARX, INC. quarterly Deferred Tax Assets, Net of Valuation Allowance in USD history and change rate from 31 Dec 2013 to 31 Dec 2024.
CANNAPHARMARX, INC. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 31 Dec 2024 was $24,978,343, a 3.2% increase year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)

Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Change (%)

CANNAPHARMARX, INC. Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$24,978,343	+$774,158	+3.2%	31 Dec 2024	10-K	10 Apr 2025	2024	FY
Q4 2023	$24,204,185			31 Dec 2023	10-K	10 Apr 2025	2024	FY
Q4 2014	$0	$0		31 Dec 2014	10-K	31 Mar 2015	2014	FY
Q4 2013	$0			31 Dec 2013	10-K	31 Mar 2015	2014	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.